Skip header information|
Wadsworth Center Home - Science in the Pursuit of Health|
Main Body

Investigators and Program Directors

Haydeh Payami

Haydeh Payami

Research Scientist, Wadsworth Center,
Computational & Structural Biology

Professor, School of Public Health, Biomedical Sciences
Lead Investigator, NeuroGenetics Research Consortium
Director, The Genomics Institute,
New York State Department of Health Wadsworth Center

Ph.D., University of California at Berkeley (1985)

E-mail: hpayami@wadsworth.org

<< Research Interests

Select Publications

  • McCulloch, C.C., D.M. Kay, S.A. Factor, A. Samii, J.G. Nutt, D.S. Higgins, A. Griffith, J.W. Roberts, B.C. Leis, J.S. Montimurro, C.P. Zabetian, H. Payami (2008). Exploring gene-environment interactions in Parkinson’s disease. Human Genet,123(3):257-65
  • Powers, K.M., D.M. Kay, S.A. Factor, Zabetian, D.S. Higgins, A. Samii, J.G. Nutt, A. Griffith, B.C. Leis, J.W. Roberts, E.D. Martinez, J.S. Montimurro, H. Checkoway, H. Payami (2008) Combined effects of smoking, coffee, and NSAIDs on Parkinson’s disease risk. Mov Disord, 23:88-95
  • Elbaz A, Nelson L, Payami H, Ioannidis JI, Fiske BK for the International Collaboration of Global Genetic Consortia. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurology 2006 Nov; 5(11):917-23
  • Kay D, Bird T, Zabetian CZ, Factor SA, Samii A, Higgins DS, Nutt JG, Roberts J, Griffith A, Leis BC, Montimurro J, Philpott S, Payami, H. Validity and Utility of a LRRK2 G2019S Mutation Test for the Diagnosis of Parkinson's Disease. Genet Test. 2006 Fall; 10(3):221-7
  • Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H. LRRK2 G2019S in Families with Parkinson's Disease Originating from Europe and the Middle East: Evidence for Two Distinct Founding Events Beginning Two Millennia Ago. Am J Hum Genet. 2006 Oct; 79(4):752-8
  • Kay, D.M., D. Moran, L. Moses, P. Poorkaj, C.P. Zabetian, J. Nutt , S.A. Factor, C.E. Yu, J.S. Montimurro, R.G. Keefe, G.D. Schellenberg, H. Payami (2006) Heterozygous parkin point mutations are as common in control subjects as in Parkinson’s patients. Ann Neurol 61, 47-54
  • Payami H, Zhu M, Montimurro J, Keefe R, McCulloch CC, Moses L. One step closer to fixing association studies: evidence for age- and gender-specific allele frequency variations and deviations from Hardy-Weinberg expectations in controls. Hum Genet. 2005 Sep 28;:1-9

Contact Information

E-mail: hpayami@wadsworth.org.